Bienvenue sur le nouveau Boursorama. Découvrez tout ce qui a changé
  1. Aide
    1. Espace client
    2. Connexion
Accès membre Boursorama

Erreur d'authentification

Vous êtes authentifié. Nous chargeons votre espace membre.

Mot de passe oublié ?

Nouveau sur Boursorama ? Devenez membre

Identifiant/Mot de passe oublié
Si vous êtes Membre de la Communauté Boursorama, veuillez indiquer l'adresse email que vous avez fournie lors de votre enregistrement pour recevoir votre identifiant et/ou ré-initialiser votre mot de passe :

Nouveau sur Boursorama ? Devenez membre





FR0000054694 NRX

Euronext Paris données temps réel
Politique d'exécution
  • ouverture


  • clôture veille


  • + haut


  • + bas


  • volume


  • valorisation

    1 281 MEUR

  • capital échangé


  • dernier échange

    28.05.18 / 12:04:40

  • limite à la baisse

    Qu'est-ce qu'une limite à la hausse/baisse ?



  • limite à la hausse

    Qu'est-ce qu'une limite à la hausse/baisse ?



  • Éligibilité


    Qu'est-ce que le SRD ?


    Qu'est-ce que le PEA ?


    Qu'est-ce que le PEA-PME ?


Autres places de cotation

  • + Alerte

  • + Portefeuille

    Ajouter NATUREX à un portefeuille virtuel

  • + Liste

    Ajouter NATUREX à mes listes


NATUREX : Q1 2015 consolidated results: The "Conquest, Cash and People" plan yields its firts encouraging results

Actusnews26/05/2015 à 18:00
  • Stability in organic growth
  • Good control over operating expenses
  • Current operating margin: 8.2%

Press release

Avignon, 26 May 2015 - Naturex, the global leader in speciality plant-based natural ingredients, announces consolidated results for the 2015 first quarter:

€ millions
1st quarter
1st quarter
Revenue 98.6 79.6 +23.9% 327.3
Gross margin 56.1 49.5 +13.5% 194.1
Gross margin (%) 56.9% 62.1%   59.3%
Operating grants 0.5 0.5 +5.8% 2.7
Other operating income 1.2 1.1 +8.1% 3.9
Staff costs (22.7) (18.0) +25.9% (77.3)
External charges (20.4) (18.8) +8.2% (83.2)
Taxes other than on income (0.6) (0.6) +9.6% (2.6)
Other operating income and expenses (0.1) (0.4) -81.9% (0.8)
Recurring EBITDA 14.1 13.2 +6.4% 36.8
Recurring EBITDA margin (%) 14.3% 16.6%   11.2%
Amortisation, depreciation and impairment (6.0) (4.6) +30.0% (22.0)
Current operating income 8.1 8.7 -6.1% 14.8
Current operating margin (%) 8.2% 10.9%   4.5%
Other non-current operating expenses - (0.2) - (7.1)
Other non-current operating income - - - -
Net operating income 8.1 8.4 -3.9% 7.7
Operating margin (%) 8.2% 10.7%   2.1%
Share of net income (loss) of equity-accounted investees (1.4) - - (0.9)
Net operating income after share of net income of equity-accounted investees 6.8 8.5 -20.5% 6.8
Net borrowing costs (1.9) (1.3) - (8.3)
Other financial income and expenses 2.1 0.2 - (0.6)
Profit before tax 6.9 7.4 -6.5% (2.0)
Income tax expense (1.7) (2.3) - (2.1)
Net income attributable to the Group 5.2 5.1 +1.1% (4.1)
Net margin (%) 5.3% 6.4%   -1.2%

Decline in organic growth halted and commercial deployment on track

Consolidated revenue for the 2015 first quarter, as reported on 28 April 2015, was €98.6 million, up 23.9% from one year earlier. This increase reflected both the impact of acquisitions with a contribution from Vegetable Juices Inc. (€9.6 million a constant exchange rates) and a currency effect resulting in particular from the US dollar's rise over the period (€9.4 million);

For the historical Group structure (€79.6 million), targeted commercial initiatives made it possible to halt the decline in organic growth after four consecutive quarters in 2014.

Performances by region and business performances were however mixed.

  • Nutrition & Health is now back on track with positive organic growth attributable in particular to the plan launched in the US at the end of 2014 to recapture growth along with good performances in the Asia-Pacific region. Europe remains a major focus of attention and a plan for re-energizing business development has already been launched.
  • Food & Beverage is performing well in the United States, benefiting from both the strong contribution by Vegetable Juices Inc. and also the continuing market transition in favour of natural foods. Europe in contrast was adversely impacted by the high base effect in relation to the 2014 first quarter in an environment that is still sluggish.
  • The Personal Care business has virtually doubled in size, confirming the pertinence of our range's positioning with a targeted customer base of leading cosmetic industry names.
  • Finally, Toll Manufacturing in the period included krill toll manufacturing sales while the Houston plant (JV with Aker BioMarine) is in a technical test phase.

The measures of the "Conquest, Cash & People" plan are starting to yield results

While Group operating margins were impacted significantly in 2014 by exceptional items registered in the fourth quarter, strict discipline applied across all operations has yielded the first encouraging signs in the quarter.

The consolidated gross margin amounted to €56.1 million, up 13.5% from the 2014 first quarter. The gross margin as a percentage of sales was 56.9% compared to 62.1% a year earlier, or down 5.2 points, reflecting:

  • A currency effect (-0.2 point) linked in particular to the Swiss francs' rise increasing the production costs of Swiss manufacturing sites when translated in the Group's financial statements. The US dollar's rise since the 2014 fourth quarter should result in a better contribution to the gross margin in the 2015 second quarter.
  • A Group structure effect (-1.8 points) reflecting the strong contribution from Vegetable Juices Inc., specialised in fruit and vegetable juice concentrates generating a gross margin lower than the Group average.
  • A product mix effect for the historical Group structure (-3.2 points) linked mainly to inventory rationalization.

Staff costs rose 25.9% to €22.7 million from €18 million in the 2014 first quarter. This increase includes in large part the €2.4 million contribution of Vegetable Juices Inc. as well as a €1.1 million currency effect resulting from the rise of selected currencies in the period (USD, CHF, GBP).
Excluding these effects, staff costs increased by €1.2 million, representing a contained increase of 6.7% for the historical Group structure primarily due to:

  • €0.4 million from a marginal increase in headcount in light of recruitments for operational posts requiring specific expertise finalised in the quarter; this effect should be limited for the 2015 full year and offset by personnel redeployment pursuant to the cost control commitments for overhead expenses;
  • €0.8 million in salary increases linked to compensation for individual employee performance and compensation indexation in certain high inflation countries also including various provision amounts (pensions, paid vacation, bonuses, etc.).

In addition, external charges represented 21% of revenue compared to 24% one year earlier, amounting to €20.4 million. This 8.2% increase was primarily attributable to Vegetable Juices Inc. (€1.6 million) and a currency effect in the period (€1.2 million). At constant currency and structure, external charges decreased by 6.6% (€1.2 million), confirming the positive effects of cost controls and discipline applied in connection with the budget management process implemented in 2015.

Recurring EBITDA amounted to €14.1 million, up 6.4%, with a recurring EBITDA margin at 14.3% compared to 16.6% in the 2014 first quarter.

Amortisation, depreciation and impairment amounted to €6 million compared to €4.6 million in the 2014 first quarter and were related to investments in 2014 (Vegetable Juices Inc., manufacturing plant in Chile, application lab in Avignon, etc.).

Current operating income amounted to €8.1 million, compared to €8.7 million in the 2014 first quarter with a current operating margin in consequence at 8.2%.

Consolidated operating profit after income from equity-accounted investees totalled €6.8 million. This includes a €1.4 million loss from the equity-accounted joint-venture with Aker BioMarine linked to charges for the Houston site qualification process and the plant remaining in a test phase in the quarter. For information, during this period, krill extraction was carried out within the Naturex's Toll Manufacturing division.

Net borrowing costs amounted to €1.9 million (1.9% of revenue) compared to €1.3 million (1.6% of revenue) in the 2014 first quarter. Readers are reminded that the Group refinanced the structured loan in June 2014 in order to take advantage of longer maturities and financing lines that were better adapted to the Group's structure.
Other financial income and expenses included income of €2.1 million compared to €0.2 million in the 2014 first quarter, resulting from a positive currency effect.

Finally, after a tax expense of €1.7 million, net income attributable to Group shareholders amounted to €5.2 million, up marginally (+1.1%) from last year's first-quarter, with a net margin standing at 5.3%.

"The 2015 first quarter confirmed the positive effects resulting from the adoption of our ‘‘Conquest, Cash & People'' plan. This renewed growth and improvement in our operating profitability coming after the heavily impacted previous year, illustrate our responsiveness and the commitment of Group teams to the principles of financial and operational discipline", commented Olivier Rigaud, Chief Executive Officer and Director of Naturex.

"Consolidating organic growth by hard-hitting commercial initiatives, along the lines of our successes in Nutrition & Health in the United States, improving performances by generating value from our investments notably in India and Chile and continuing efforts to control operating expenses and staff costs are necessary conditions for activating the drivers for sustainable profitability beginning in the second half of 2015".


You can receive all financial information of Naturex free of charge by signing up at:


  • Financial schedule
    2015 H1 sales 29 July 2015
    2015 first-half results 16 September 2015
  • Upcoming events
    AGM (Paris) 24 June 2015
    Strategy 2020 Presentation (Paris) 30 June 2015


Naturex has been listed since October 1996 on Euronext in Paris, Segment B

  Total number of shares comprising the share capital: 9,221,113 (April2015)
ISIN FR0000054694

NATUREX is a component of the CACT, Enternext CAC PEA-PME 150, CAC Small & Mid, CAC Small, Gaïa Index.
Naturex is eligible for the "long only" Deferred Settlement Service (SRD) and French equity plans (PEA and PEA-PME).
Naturex established a Sponsored Level 1 American Depositary Receipt (ADR) program in the United States. Under this facility, Naturex's ADRs are traded over-the-counter in the United States under the symbol NTUXY.



About Naturex

Naturex is the global leader in speciality plant-based natural ingredients. The Group is organised around three strategic markets (Food & Beverage, Nutrition & Health and Personal Care) and produces and markets speciality plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.

Naturex's head office is based in Avignon. The company employs 1,600 people with 8 sourcing offices located throughout the world and high-performance manufacturing operations across 16 sites in Europe, Morocco, the United States, Brazil, Australia and India. It also has a global commercial presence through a dedicated network of sales offices in more than 20 countries.

  • Contacts
Carole Alexandre
Investor Relations
Tel.: +33 (0)4 90 23 78 28
Anne Catherine Bonjour
Actus Finance Press Relations
Tel.: +33 (0)1 53 67 36 93


* "Conquest, Cash & People": A 2015 action plan to revive sales for a return to growth (Conquest), optimise working capital and apply rigorous financial discipline (Cash) and strengthen human capital to federate our teams and promote the emergence of new talents (People).

Information réglementée
Communiqués au titre de l'obligation d'information permanente :
- Communiqué sur comptes, résultats, chiffres d'affaires
Full and original press release in PDF:

Valeurs associées


Mes listes




Les Risques en Bourse


Note d'information importante

Chère Cliente, Cher Client,

Nous souhaitons vous donner quelques règles à suivre pour investir dans les meilleures conditions et vous présenter les risques potentiels auxquels vous êtes susceptibles d'être exposés.

Vos connaissances, Votre profil d'investisseur
Tout d'abord évaluez vos connaissances boursières et financières et formez-vous en consultant le Guide de l'Investisseur, véritable introduction à la bourse et à l'épargne qui est disponible sur votre site Boursorama Banque sous la rubrique «Aide/Formation».
Définissez ensuite votre profil d'investisseur (prudent, équilibré, dynamique) et vos objectifs (durée de placement, rentabilité …). Ce constat vous permettra de vous orienter vers les produits et les marchés qui vous sont le mieux adaptés.

Pensez à vos besoins de liquidité
Adaptez votre durée de placement (1 mois, 1 an, 5 ans, …) à vos besoins de liquidités (projets, impôts …) et en tout état de cause, n'investissez pas en Bourse une partie trop importante de votre patrimoine.

La composition de votre portefeuille
Etudiez la composition de votre portefeuille : diversifiez vos placements afin de réduire au maximum le risque inhérent à un support ou à un secteur en particulier et n'investissez pas dans les produits optionnels (warrants, certificats), fortement risqués, si votre portefeuille n'est pas suffisamment important.

Connaître la vie des Sociétés
Renseignez-vous sur la société au sein de laquelle vous envisagez d'investir (actualités, santé financière, opérations à venir, …).

Agir en connaissance de cause
Soyez conscient des risques auxquels vous êtes exposés : de fait, si certains produits (actions volatiles, warrants, certificats, future…) ou certains modes d'investissement (Service de Règlement Différé) augmentent les espérances de gain, ils accroissent aussi fortement le risque de perte (totale). Ainsi, une connaissance technique préalable approfondie est requise, c'est pourquoi nous conseillons aux néophytes de s'écarter de ce type de produits.

Des risques différents selon les marchés
Prenez connaissance des caractéristiques des marchés sur lesquels vous allez investir : vous êtes confrontés à un risque variable (liquidité, volatilité, niveau d'information, change…) selon les marchés sur lesquels vous décidez d'intervenir (Premier Marché, Second Marché, Nouveau marché, Marché Libre, Marché étranger…).

Figez vos pertes
Enfin, la règle d'or à retenir est de savoir figer ses pertes : à vous de définir le montant de perte acceptable dès le début et une fois ce niveau atteint agissez en conséquence.

En appliquant ces quelques règles de bonnes conduite vous serez à même de mieux appréhender votre risque lorsque vous allez investir sur les Marchés

Un ensemble de cours complets sur la Bourse est également mis à votre disposition gratuitement et que vous pouvez retrouver sur votre site Boursorama Banque dans la rubrique «Aide/Formation». Si des questions resteraient en suspend, n'hésitez pas à contacter votre agence qui est à votre disposition.

L'équipe de Boursorama Banque.